Copyright Reports & Markets. All rights reserved.

Global New Drug Modeling Solution Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of New Drug Modeling Solution
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of New Drug Modeling Solution by Type
    • 1.3.1 Overview: Global New Drug Modeling Solution Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global New Drug Modeling Solution Consumption Value Market Share by Type in 2022
    • 1.3.3 Database
    • 1.3.4 Software
    • 1.3.5 Others
  • 1.4 Global New Drug Modeling Solution Market by Application
    • 1.4.1 Overview: Global New Drug Modeling Solution Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Drug Discovery and Development
    • 1.4.3 Computational Physiological Medicine
    • 1.4.4 Disease Modeling
    • 1.4.5 Others
  • 1.5 Global New Drug Modeling Solution Market Size & Forecast
  • 1.6 Global New Drug Modeling Solution Market Size and Forecast by Region
    • 1.6.1 Global New Drug Modeling Solution Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global New Drug Modeling Solution Market Size by Region, (2018-2029)
    • 1.6.3 North America New Drug Modeling Solution Market Size and Prospect (2018-2029)
    • 1.6.4 Europe New Drug Modeling Solution Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific New Drug Modeling Solution Market Size and Prospect (2018-2029)
    • 1.6.6 South America New Drug Modeling Solution Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa New Drug Modeling Solution Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 JSR Corporation(Crown Bioscience)
    • 2.1.1 JSR Corporation(Crown Bioscience) Details
    • 2.1.2 JSR Corporation(Crown Bioscience) Major Business
    • 2.1.3 JSR Corporation(Crown Bioscience) New Drug Modeling Solution Product and Solutions
    • 2.1.4 JSR Corporation(Crown Bioscience) New Drug Modeling Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 JSR Corporation(Crown Bioscience) Recent Developments and Future Plans
  • 2.2 Chemical Computing Group ULC
    • 2.2.1 Chemical Computing Group ULC Details
    • 2.2.2 Chemical Computing Group ULC Major Business
    • 2.2.3 Chemical Computing Group ULC New Drug Modeling Solution Product and Solutions
    • 2.2.4 Chemical Computing Group ULC New Drug Modeling Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Chemical Computing Group ULC Recent Developments and Future Plans
  • 2.3 Nimbus Therapeutics
    • 2.3.1 Nimbus Therapeutics Details
    • 2.3.2 Nimbus Therapeutics Major Business
    • 2.3.3 Nimbus Therapeutics New Drug Modeling Solution Product and Solutions
    • 2.3.4 Nimbus Therapeutics New Drug Modeling Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Nimbus Therapeutics Recent Developments and Future Plans
  • 2.4 schrodinger, Inc
    • 2.4.1 schrodinger, Inc Details
    • 2.4.2 schrodinger, Inc Major Business
    • 2.4.3 schrodinger, Inc New Drug Modeling Solution Product and Solutions
    • 2.4.4 schrodinger, Inc New Drug Modeling Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 schrodinger, Inc Recent Developments and Future Plans
  • 2.5 Genedata AG
    • 2.5.1 Genedata AG Details
    • 2.5.2 Genedata AG Major Business
    • 2.5.3 Genedata AG New Drug Modeling Solution Product and Solutions
    • 2.5.4 Genedata AG New Drug Modeling Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Genedata AG Recent Developments and Future Plans
  • 2.6 Biognos AB
    • 2.6.1 Biognos AB Details
    • 2.6.2 Biognos AB Major Business
    • 2.6.3 Biognos AB New Drug Modeling Solution Product and Solutions
    • 2.6.4 Biognos AB New Drug Modeling Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Biognos AB Recent Developments and Future Plans
  • 2.7 Compugen Ltd
    • 2.7.1 Compugen Ltd Details
    • 2.7.2 Compugen Ltd Major Business
    • 2.7.3 Compugen Ltd New Drug Modeling Solution Product and Solutions
    • 2.7.4 Compugen Ltd New Drug Modeling Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Compugen Ltd Recent Developments and Future Plans
  • 2.8 Dassault Systemes
    • 2.8.1 Dassault Systemes Details
    • 2.8.2 Dassault Systemes Major Business
    • 2.8.3 Dassault Systemes New Drug Modeling Solution Product and Solutions
    • 2.8.4 Dassault Systemes New Drug Modeling Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Dassault Systemes Recent Developments and Future Plans
  • 2.9 Acellera
    • 2.9.1 Acellera Details
    • 2.9.2 Acellera Major Business
    • 2.9.3 Acellera New Drug Modeling Solution Product and Solutions
    • 2.9.4 Acellera New Drug Modeling Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Acellera Recent Developments and Future Plans
  • 2.10 lnstem(Leadscope)
    • 2.10.1 lnstem(Leadscope) Details
    • 2.10.2 lnstem(Leadscope) Major Business
    • 2.10.3 lnstem(Leadscope) New Drug Modeling Solution Product and Solutions
    • 2.10.4 lnstem(Leadscope) New Drug Modeling Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 lnstem(Leadscope) Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global New Drug Modeling Solution Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of New Drug Modeling Solution by Company Revenue
    • 3.2.2 Top 3 New Drug Modeling Solution Players Market Share in 2022
    • 3.2.3 Top 6 New Drug Modeling Solution Players Market Share in 2022
  • 3.3 New Drug Modeling Solution Market: Overall Company Footprint Analysis
    • 3.3.1 New Drug Modeling Solution Market: Region Footprint
    • 3.3.2 New Drug Modeling Solution Market: Company Product Type Footprint
    • 3.3.3 New Drug Modeling Solution Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global New Drug Modeling Solution Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global New Drug Modeling Solution Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global New Drug Modeling Solution Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global New Drug Modeling Solution Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America New Drug Modeling Solution Consumption Value by Type (2018-2029)
  • 6.2 North America New Drug Modeling Solution Consumption Value by Application (2018-2029)
  • 6.3 North America New Drug Modeling Solution Market Size by Country
    • 6.3.1 North America New Drug Modeling Solution Consumption Value by Country (2018-2029)
    • 6.3.2 United States New Drug Modeling Solution Market Size and Forecast (2018-2029)
    • 6.3.3 Canada New Drug Modeling Solution Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico New Drug Modeling Solution Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe New Drug Modeling Solution Consumption Value by Type (2018-2029)
  • 7.2 Europe New Drug Modeling Solution Consumption Value by Application (2018-2029)
  • 7.3 Europe New Drug Modeling Solution Market Size by Country
    • 7.3.1 Europe New Drug Modeling Solution Consumption Value by Country (2018-2029)
    • 7.3.2 Germany New Drug Modeling Solution Market Size and Forecast (2018-2029)
    • 7.3.3 France New Drug Modeling Solution Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom New Drug Modeling Solution Market Size and Forecast (2018-2029)
    • 7.3.5 Russia New Drug Modeling Solution Market Size and Forecast (2018-2029)
    • 7.3.6 Italy New Drug Modeling Solution Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific New Drug Modeling Solution Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific New Drug Modeling Solution Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific New Drug Modeling Solution Market Size by Region
    • 8.3.1 Asia-Pacific New Drug Modeling Solution Consumption Value by Region (2018-2029)
    • 8.3.2 China New Drug Modeling Solution Market Size and Forecast (2018-2029)
    • 8.3.3 Japan New Drug Modeling Solution Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea New Drug Modeling Solution Market Size and Forecast (2018-2029)
    • 8.3.5 India New Drug Modeling Solution Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia New Drug Modeling Solution Market Size and Forecast (2018-2029)
    • 8.3.7 Australia New Drug Modeling Solution Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America New Drug Modeling Solution Consumption Value by Type (2018-2029)
  • 9.2 South America New Drug Modeling Solution Consumption Value by Application (2018-2029)
  • 9.3 South America New Drug Modeling Solution Market Size by Country
    • 9.3.1 South America New Drug Modeling Solution Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil New Drug Modeling Solution Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina New Drug Modeling Solution Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa New Drug Modeling Solution Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa New Drug Modeling Solution Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa New Drug Modeling Solution Market Size by Country
    • 10.3.1 Middle East & Africa New Drug Modeling Solution Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey New Drug Modeling Solution Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia New Drug Modeling Solution Market Size and Forecast (2018-2029)
    • 10.3.4 UAE New Drug Modeling Solution Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 New Drug Modeling Solution Market Drivers
  • 11.2 New Drug Modeling Solution Market Restraints
  • 11.3 New Drug Modeling Solution Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 New Drug Modeling Solution Industry Chain
  • 12.2 New Drug Modeling Solution Upstream Analysis
  • 12.3 New Drug Modeling Solution Midstream Analysis
  • 12.4 New Drug Modeling Solution Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global New Drug Modeling Solution market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
    The Global Info Research report includes an overview of the development of the New Drug Modeling Solution industry chain, the market status of Drug Discovery and Development (Database, Software), Computational Physiological Medicine (Database, Software), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of New Drug Modeling Solution.
    Regionally, the report analyzes the New Drug Modeling Solution markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global New Drug Modeling Solution market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the New Drug Modeling Solution market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the New Drug Modeling Solution industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Database, Software).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the New Drug Modeling Solution market.
    Regional Analysis: The report involves examining the New Drug Modeling Solution market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the New Drug Modeling Solution market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to New Drug Modeling Solution:
    Company Analysis: Report covers individual New Drug Modeling Solution players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards New Drug Modeling Solution This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Drug Discovery and Development, Computational Physiological Medicine).
    Technology Analysis: Report covers specific technologies relevant to New Drug Modeling Solution. It assesses the current state, advancements, and potential future developments in New Drug Modeling Solution areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the New Drug Modeling Solution market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    New Drug Modeling Solution market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Database
    Software
    Others
    Market segment by Application
    Drug Discovery and Development
    Computational Physiological Medicine
    Disease Modeling
    Others
    Market segment by players, this report covers
    JSR Corporation(Crown Bioscience)
    Chemical Computing Group ULC
    Nimbus Therapeutics
    schrodinger, Inc
    Genedata AG
    Biognos AB
    Compugen Ltd
    Dassault Systemes
    Acellera
    lnstem(Leadscope)
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe New Drug Modeling Solution product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of New Drug Modeling Solution, with revenue, gross margin and global market share of New Drug Modeling Solution from 2018 to 2023.
    Chapter 3, the New Drug Modeling Solution competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and New Drug Modeling Solution market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
    Chapter 12, the key raw materials and key suppliers, and industry chain of New Drug Modeling Solution.
    Chapter 13, to describe New Drug Modeling Solution research findings and conclusion.

    Buy now